Pulmonary Hypertension

The FDA did not meet its Prescription Drug User Fee Act goal date that would extend Yutrepia as a treatment for patients with pulmonary hypertension associated with interstitial lung disease, according to a press release.

Cardiovascular disease often occurs among patients with both COPD and obstructive sleep apnea, but there are little data evaluating how the overlap impacts disease severity, according to a presentation at the 2023 GOLD COPD conference.

Among preterm infants with bronchopulmonary dysplasia, pulmonary hypertension appeared linked to extended intermittent hypoxemia events and death, according to results published in American Journal of Respiratory and Critical Care Medicine.

HONOLULU — Patients with chronic thromboembolism pulmonary hypertension and a higher median income had better 6-minute walk distance and hemodynamics than those with a low income, according to a presentation at the CHEST Annual Meeting.

HONOLULU — Patients with pulmonary hypertension who also had diabetes showed increased likelihood for mortality compared with patients without diabetes, according to a systemic review presented at the CHEST Annual Meeting.

HONOLULU — Patients with pulmonary hypertension hospitalized with acute respiratory distress syndrome had increased odds for mortality, extended stays and higher costs, according to research presented at the CHEST Annual Meeting.

Patients with pulmonary arterial hypertension receiving sotatercept, a novel activin signaling inhibitor, plus background therapy are expected to live longer, according to a European Respiratory Society International Congress presentation.